October 18th 2024
At ID Week 2024, in a late-breaking presentation, investigators are reporting it is safe to cut the antibiotic regimen in half without endangering patients for these infections.
The Confluence of New Antibiotics, Treatment Guidelines, and Antimicrobial Stewardship in SSTIs
December 6th 2022With the proliferation of therapies for skin and soft tissue infections (SSTIs), a clinician discusses how providers can appropriately find the balance between these novel therapies, the existing treatment guidelines, and stewardship.
Watch
What’s New in 2022 From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
October 26th 2022The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing held a virtual winter meeting and a hybrid summer meeting in 2022. Ad hoc working groups have several breakpoint revisions underway for multiple organism-drug combinations.
Read More
Antibiotics for S aureus Bacteremia Adapted to Patient's Access to Treatment
October 5th 2022Oral antibiotics after partial completion of intravenous regimen for S aureus bacteremia improves outcomes of persons who inject drugs (PWID), which is a population that often has limited access to treatment.
Read More
The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship
September 27th 2022The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
Read More